![](/img/cover-not-exists.png)
PSR1 COST-EFFECTIVENESS OF CLOPIDOGREL VERSUS ASPIRIN IN THE PREVENTION OF ISCHEMIC EVENTS IN STROKE AND TIA PATIENTS: A FOUR-EUROPEAN COUNTRY ANALYSIS
AJ Palmer, S Roze, G Hankey, Z Hakimi, J Spiesser, P Carita, S GabrielVolume:
8
Year:
2005
Language:
english
DOI:
10.1016/s1098-3015(10)62878-1
File:
PDF, 67 KB
english, 2005